Psychotic episodes -- like hallucinations or delusions -- related to dementia can be scary for all involved. But there are ways to diagnose and treat the condition.

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Patients with dementia due to neurodegenerative disease can have dementia-related psychosis. The effects of the oral 5-HT2A inverse agonist and antagonist pimavanserin on psychosis related to vario ...

(StatePoint) Approximately 2.4 million people or 30 percent of people living with dementia in the U.S. may experience hallucinations and delusions associated with dementia-related psychosis. These … ...

They found that across multiple different psychotic disorders, and regardless of the age at which someone first developed their mental illness, there was a higher risk of dementia later in life.

Experts studied over 1.25million people in the UK with Covid and found new diagnoses of psychosis, dementia, seizures and brain fog were more common during the two years after.

The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s disease. Nuplazid was approved in ...

Dementia-related psychosis is more than just upsetting. It can affect the health and safety of the person with dementia, and those who care for them.